Abstract | INTRODUCTION: PATIENTS AND METHODS: Using the Center for International Blood and Marrow Transplant Research (CIBMTR) database, we identified 36 patients with IgD and 11 patients with IgM myeloma among 3578 myeloma patients who received intensive therapy and auto-HCT over a 10-year period. RESULTS: The progression-free and overall survival probabilities at 3 years were 38% (95% CI, 21%-56%) and 69% (95% CI, 51%-84%) for IgD myeloma, and 47% (95% CI, 17%-78%) and 68% (95% CI, 36%-93%), respectively, for IgM disease. Although formal statistical analysis was limited by the small sample size, these results were comparable to those for IgG and IgA patients autografted during the same time period. Transplantation-related mortality and disease relapse/progression of myeloma were also similar for all isotypes. CONCLUSION: This analysis demonstrates comparable outcomes in all immunoglobulin isotypes. Therefore, auto-HCT should be offered to eligible patients with IgD and IgM myeloma.
|
Authors | Donna E Reece, David H Vesole, Smriti Shrestha, Mei-Jie Zhang, Waleska S Pérez, Angela Dispenzieri, Gustavo A Milone, Muneer Abidi, Harold Atkins, Asad Bashey, Christopher N Bredeson, Willem Bujan Boza, César O Freytes, Robert Peter Gale, James L Gajewski, John Gibson, Gregory A Hale, Shaji Kumar, Robert A Kyle, Hillard M Lazarus, Philip L McCarthy, Santiago Pavlovsky, Vivek Roy, Daniel J Weisdorf, Peter H Wiernik, Parameswaran N Hari |
Journal | Clinical lymphoma, myeloma & leukemia
(Clin Lymphoma Myeloma Leuk)
Vol. 10
Issue 6
Pg. 458-63
(Dec 2010)
ISSN: 2152-2669 [Electronic] United States |
PMID | 21156462
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Immunoglobulin D
- Immunoglobulin M
|
Topics |
- Adult
- Aged
- Combined Modality Therapy
- Databases, Factual
(statistics & numerical data)
- Disease Progression
- Drug Therapy
(methods)
- Female
- Hematopoietic Stem Cell Transplantation
(methods)
- Humans
- Immunoglobulin D
(immunology)
- Immunoglobulin M
(immunology)
- International Cooperation
- Male
- Middle Aged
- Multiple Myeloma
(drug therapy, immunology, surgery)
- Prognosis
- Recurrence
- Retrospective Studies
- Survival Analysis
- Time Factors
- Transplantation, Autologous
- Treatment Outcome
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|